Glaukos has concluded patient enrolment in its US 510 (k) pivotal trial assessing the Preserflo MicroShunt drainage device in adults with primary open-angle glaucoma. The study targets patients whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results